goal_code,goal_labelEN,goal_descEN,target_code,target_descEN,indicator_code,indicator_reference,indicator_descEN,series_release,series_tags,series,seriesDescription,geoAreaCode,geoAreaName,level,parentCode,parentName,type,X,Y,ISO3,UN_Member,Country_Profile,timeCoverage,geoInfoUrl,years,min_year,max_year,n_years,unitsCode,unitsDesc,reportingTypeCode,reportingTypeDesc,value_2000,value_2001,value_2002,value_2003,value_2004,value_2005,value_2006,value_2007,value_2008,value_2009,value_2010,value_2011,value_2012,value_2013,value_2014,value_2015,value_2016,value_2017,value_2018,latest_value,basePeriod,valueDetails,footnotes,sources,timeDetails,nature
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),1,World,1,,,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,72.0,73.0,73.0,74.0,76.0,77.0,78.0,79.0,81.0,83.0,84.0,85.0,84.0,84.0,84.0,85.0,86.0,86.0,86.0,86.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),100,Bulgaria,4,151,Eastern Europe,Country,25.23763153,42.75731323,BGR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,94.0,93.0,96.0,95.0,96.0,95.0,95.0,95.0,94.0,94.0,95.0,95.0,95.0,88.0,91.0,92.0,92.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),104,Myanmar,4,35,South-Eastern Asia,Country,96.51752295,21.19332882,MMR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,82.0,73.0,79.0,78.0,82.0,73.0,82.0,86.0,85.0,90.0,90.0,84.0,84.0,75.0,88.0,89.0,90.0,89.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),108,Burundi,5,14,Eastern Africa,Country,29.89080992,-3.366387428,BDI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,80.0,81.0,81.0,82.0,83.0,87.0,92.0,99.0,92.0,94.0,96.0,96.0,96.0,96.0,95.0,94.0,94.0,91.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),11,Western Africa,4,202,Sub-Saharan Africa,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,42.0,42.0,43.0,47.0,50.0,53.0,56.0,59.0,65.0,71.0,67.0,62.0,60.0,60.0,60.0,61.0,69.0,70.0,69.0,69.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),112,Belarus,4,151,Eastern Europe,Country,28.04940161,53.54193075,BLR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,50.0,99.0,99.0,99.0,95.0,97.0,96.0,98.0,98.0,98.0,98.0,97.0,99.0,98.0,97.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),116,Cambodia,4,35,South-Eastern Asia,Country,104.922836,12.71163737,KHM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,59.0,60.0,54.0,69.0,85.0,82.0,80.0,82.0,91.0,94.0,90.0,91.0,90.0,86.0,91.0,92.0,93.0,93.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),12,Algeria,4,15,Northern Africa,Country,2.678164227,28.15940032,DZA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,86.0,89.0,86.0,87.0,86.0,88.0,95.0,95.0,93.0,95.0,95.0,95.0,95.0,95.0,95.0,95.0,91.0,91.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),120,Cameroon,5,17,Middle Africa,Country,12.7419827,5.692387031,CMR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,62.0,63.0,66.0,73.0,73.0,80.0,81.0,82.0,84.0,80.0,84.0,82.0,85.0,89.0,87.0,84.0,85.0,86.0,79.0,79.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),124,Canada,4,21,Northern America,Country,-101.6575058,57.72360191,CAN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,89.0,89.0,88.0,91.0,91.0,93.0,95.0,94.0,92.0,91.0,89.0,87.0,91.0,91.0,91.0,91.0,91.0,91.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),13,Central America,4,419,Latin America and the Caribbean,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,94.0,94.0,95.0,95.0,96.0,96.0,96.0,95.0,94.0,95.0,95.0,98.0,85.0,87.0,86.0,92.0,86.0,88.0,88.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),132,Cabo Verde,5,11,Western Africa,Country,-23.63544151,15.07791834,CPV,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,90.0,91.0,92.0,93.0,95.0,96.0,98.0,99.0,99.0,99.0,90.0,94.0,93.0,95.0,93.0,96.0,96.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),135,Caucasus and Central Asia,1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,93.0,93.0,92.0,91.0,94.0,93.0,92.0,94.0,95.0,96.0,97.0,97.0,97.0,97.0,98.0,94.0,97.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),14,Eastern Africa,4,202,Sub-Saharan Africa,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,60.0,62.0,64.0,66.0,67.0,69.0,70.0,72.0,73.0,76.0,78.0,79.0,79.0,77.0,79.0,82.0,82.0,82.0,83.0,83.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),140,Central African Republic,5,17,Middle Africa,Country,20.93559492,7.003720791,CAF,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,37.0,40.0,44.0,47.0,51.0,54.0,51.0,48.0,45.0,42.0,45.0,47.0,47.0,23.0,47.0,47.0,47.0,47.0,47.0,47.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),142,Asia,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,73.0,74.0,73.0,74.0,77.0,77.0,78.0,78.0,81.0,84.0,85.0,87.0,87.0,87.0,88.0,88.0,90.0,90.0,89.0,89.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),143,Central Asia,3,142,Asia,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,96.0,96.0,96.0,95.0,93.0,96.0,94.0,94.0,96.0,97.0,98.0,98.0,98.0,98.0,97.0,98.0,94.0,98.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),144,Sri Lanka,4,34,Southern Asia,Country,80.70489654,7.614693343,LKA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,98.0,98.0,99.0,97.0,99.0,98.0,98.0,98.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),145,Western Asia,3,142,Asia,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,84.0,85.0,81.0,77.0,83.0,84.0,83.0,84.0,86.0,88.0,87.0,87.0,83.0,84.0,83.0,82.0,84.0,86.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),148,Chad,5,17,Middle Africa,Country,18.66618401,15.36279341,TCD,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,36.0,26.0,25.0,23.0,21.0,25.0,40.0,28.0,19.0,24.0,39.0,33.0,40.0,39.0,36.0,42.0,41.0,41.0,41.0,41.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),15,Northern Africa,3,2,Africa,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,86.0,88.0,84.0,87.0,89.0,91.0,92.0,93.0,94.0,93.0,95.0,96.0,94.0,96.0,95.0,94.0,95.0,94.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),150,Europe,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,95.0,96.0,95.0,96.0,96.0,97.0,97.0,96.0,95.0,94.0,94.0,95.0,95.0,92.0,91.0,91.0,93.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),151,Eastern Europe,3,150,Europe,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,98.0,95.0,98.0,98.0,98.0,98.0,97.0,94.0,90.0,90.0,94.0,94.0,86.0,86.0,86.0,90.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),152,Chile,5,5,South America,Country,-71.23029019,-35.2652885,CHL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,97.0,97.0,96.0,93.0,91.0,94.0,96.0,95.0,94.0,92.0,94.0,90.0,91.0,95.0,96.0,95.0,93.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),154,Northern Europe,3,150,Europe,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,92.0,92.0,92.0,92.0,93.0,92.0,93.0,93.0,93.0,94.0,94.0,95.0,95.0,95.0,95.0,95.0,94.0,94.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),155,Western Europe,3,150,Europe,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,95.0,95.0,96.0,96.0,96.0,97.0,97.0,97.0,96.0,97.0,97.0,97.0,96.0,96.0,95.0,95.0,95.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),156,China,4,30,Eastern Asia,Country,104.1403375,32.30955217,CHN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,86.0,86.0,86.0,87.0,87.0,93.0,93.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),17,Middle Africa,4,202,Sub-Saharan Africa,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,39.0,34.0,39.0,41.0,47.0,51.0,53.0,62.0,59.0,61.0,60.0,65.0,68.0,68.0,71.0,72.0,70.0,71.0,71.0,71.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),170,Colombia,5,5,South America,Country,-73.07446751,3.888209046,COL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,79.0,80.0,81.0,92.0,89.0,93.0,93.0,93.0,92.0,92.0,88.0,85.0,91.0,91.0,90.0,91.0,91.0,92.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),174,Comoros,5,14,Eastern Africa,Country,43.34234565,-11.66121732,COM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,70.0,70.0,89.0,80.0,76.0,68.0,69.0,75.0,81.0,83.0,74.0,83.0,86.0,87.0,87.0,91.0,91.0,91.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),178,Congo,5,11,Western Africa,Country,15.22052612,-0.840544119,COG,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,33.0,31.0,41.0,50.0,67.0,62.0,73.0,72.0,79.0,78.0,74.0,82.0,85.0,85.0,90.0,80.0,71.0,69.0,75.0,75.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),18,Southern Africa,4,202,Sub-Saharan Africa,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,75.0,73.0,72.0,72.0,76.0,82.0,85.0,86.0,83.0,82.0,79.0,77.0,74.0,83.0,86.0,86.0,78.0,78.0,77.0,77.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),180,Democratic Republic of the Congo,5,17,Middle Africa,Country,23.65496507,-2.877154732,COD,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,40.0,30.0,38.0,41.0,54.0,60.0,62.0,70.0,65.0,72.0,60.0,74.0,75.0,74.0,80.0,81.0,79.0,81.0,81.0,81.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),184,Cook Islands,4,61,Polynesia,Country,-159.7711391,-21.22696458,COK,0,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,92.0,90.0,97.0,96.0,99.0,99.0,99.0,99.0,99.0,82.0,99.0,93.0,98.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),188,Costa Rica,5,13,Central America,Country,-84.19712782,9.970998683,CRI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,88.0,91.0,94.0,88.0,90.0,91.0,89.0,89.0,90.0,86.0,88.0,85.0,91.0,95.0,91.0,92.0,97.0,96.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),19,Americas,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,91.0,92.0,93.0,94.0,94.0,94.0,94.0,93.0,94.0,94.0,94.0,93.0,91.0,90.0,91.0,91.0,88.0,87.0,87.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),191,Croatia,4,39,Southern Europe,Country,17.95874553,45.45172212,HRV,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,94.0,95.0,94.0,96.0,96.0,96.0,96.0,96.0,96.0,97.0,96.0,96.0,96.0,95.0,94.0,93.0,92.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),192,Cuba,5,29,Caribbean,Country,-79.54460144,22.10030366,CUB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,98.0,99.0,72.0,88.0,89.0,89.0,93.0,95.0,96.0,96.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),196,Cyprus,4,145,Western Asia,Country,33.22285964,35.05659437,CYP,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,98.0,98.0,98.0,98.0,97.0,97.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,97.0,97.0,97.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),199,Least Developed Countries (LDC),1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,57.0,58.0,60.0,63.0,68.0,69.0,71.0,74.0,74.0,76.0,76.0,78.0,77.0,76.0,78.0,80.0,80.0,81.0,80.0,80.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),2,Africa,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,56.0,56.0,57.0,60.0,62.0,65.0,67.0,70.0,72.0,75.0,74.0,74.0,73.0,73.0,74.0,76.0,78.0,78.0,78.0,78.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),20,Andorra,4,39,Southern Europe,Country,1.576257417,42.54548611,AND,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,96.0,97.0,99.0,99.0,98.0,93.0,96.0,99.0,99.0,99.0,99.0,99.0,96.0,97.0,97.0,98.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),202,Sub-Saharan Africa,3,2,Africa,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,50.0,50.0,52.0,55.0,58.0,61.0,63.0,66.0,68.0,72.0,70.0,70.0,70.0,69.0,71.0,72.0,75.0,75.0,75.0,75.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),203,Czechia,4,151,Eastern Europe,Country,15.33151382,49.73913871,CZE,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,98.0,98.0,97.0,98.0,97.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,98.0,97.0,97.0,96.0,96.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),204,Benin,5,11,Western Africa,Country,2.339933594,9.65401646,BEN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,78.0,76.0,75.0,73.0,72.0,70.0,74.0,82.0,75.0,79.0,76.0,75.0,80.0,77.0,74.0,74.0,76.0,76.0,76.0,76.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),208,Denmark,4,154,Northern Europe,Country,9.326571283,56.03829721,DNK,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,98.0,96.0,95.0,93.0,93.0,87.0,88.0,89.0,90.0,91.0,94.0,94.0,94.0,93.0,94.0,98.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),21,Northern America,3,19,Americas,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,94.0,94.0,96.0,96.0,96.0,96.0,96.0,96.0,95.0,94.0,95.0,94.0,94.0,95.0,95.0,95.0,95.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),212,Dominica,5,29,Caribbean,Country,-61.3493756,15.43391378,DMA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,98.0,99.0,99.0,98.0,95.0,96.0,96.0,99.0,98.0,98.0,97.0,96.0,97.0,98.0,99.0,91.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),214,Dominican Republic,5,29,Caribbean,Country,-70.49847576,18.89832088,DOM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,78.0,72.0,82.0,79.0,79.0,87.0,89.0,85.0,82.0,82.0,88.0,84.0,85.0,83.0,91.0,85.0,87.0,84.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),218,Ecuador,5,5,South America,Country,-78.37005241,-1.447785891,ECU,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,87.0,89.0,88.0,87.0,88.0,92.0,96.0,96.0,96.0,94.0,91.0,88.0,87.0,87.0,83.0,78.0,83.0,85.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),222,El Salvador,5,13,Central America,Country,-88.86862995,13.73603564,SLV,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,92.0,81.0,94.0,90.0,89.0,96.0,99.0,98.0,91.0,89.0,89.0,92.0,92.0,94.0,91.0,93.0,85.0,81.0,81.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),226,Equatorial Guinea,5,17,Middle Africa,Country,10.46535826,1.565792376,GNQ,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,34.0,35.0,36.0,37.0,38.0,39.0,40.0,41.0,42.0,43.0,44.0,41.0,26.0,6.0,24.0,16.0,19.0,25.0,25.0,25.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),231,Ethiopia,5,14,Eastern Africa,Country,39.63505296,8.631223181,ETH,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,30.0,32.0,35.0,37.0,40.0,44.0,46.0,50.0,54.0,58.0,61.0,65.0,62.0,59.0,61.0,73.0,73.0,73.0,72.0,72.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),232,Eritrea,5,14,Eastern Africa,Country,38.11074289,16.12894644,ERI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,81.0,86.0,90.0,93.0,98.0,96.0,94.0,95.0,95.0,95.0,95.0,94.0,94.0,94.0,94.0,95.0,95.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),233,Estonia,4,154,Northern Europe,Country,25.84093481,58.68487172,EST,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,94.0,94.0,94.0,94.0,96.0,95.0,95.0,95.0,95.0,94.0,93.0,94.0,94.0,93.0,93.0,93.0,93.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),24,Angola,5,17,Middle Africa,Country,17.57817062,-12.33724746,AGO,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,19.0,26.0,27.0,22.0,19.0,15.0,8.0,43.0,41.0,34.0,52.0,46.0,52.0,54.0,55.0,55.0,55.0,52.0,59.0,59.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),242,Fiji,4,54,Melanesia,Country,177.9660884,-17.83301566,FJI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,91.0,93.0,94.0,95.0,96.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),246,Finland,4,154,Northern Europe,Country,23.308447,61.91586738,FIN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,98.0,98.0,98.0,98.0,97.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,98.0,98.0,97.0,92.0,89.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),250,France,4,155,Western Europe,Country,2.457288129,46.62660861,FRA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,97.0,97.0,98.0,98.0,99.0,99.0,99.0,98.0,99.0,99.0,99.0,99.0,98.0,97.0,96.0,96.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),262,Djibouti,5,14,Eastern Africa,Country,42.18274707,11.56004161,DJI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,46.0,53.0,62.0,68.0,64.0,71.0,72.0,88.0,89.0,89.0,88.0,87.0,81.0,82.0,78.0,84.0,68.0,76.0,84.0,84.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),266,Gabon,5,17,Middle Africa,Country,11.78727747,-0.60687619,GAB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,45.0,45.0,45.0,45.0,45.0,45.0,45.0,81.0,82.0,76.0,67.0,75.0,82.0,79.0,70.0,80.0,75.0,75.0,70.0,70.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),268,Georgia,4,145,Western Asia,Country,43.3713615,42.04813028,GEO,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,80.0,87.0,84.0,75.0,78.0,82.0,88.0,98.0,92.0,88.0,92.0,94.0,92.0,93.0,91.0,94.0,92.0,91.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),270,Gambia,5,11,Western Africa,Country,-15.39944785,13.45295927,GMB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,80.0,87.0,87.0,87.0,87.0,95.0,95.0,95.0,96.0,98.0,97.0,96.0,98.0,97.0,96.0,97.0,95.0,92.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),275,State of Palestine,4,145,Western Asia,Country,35.25694122,31.94347933,PSE,0,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,97.0,97.0,98.0,96.0,96.0,96.0,99.0,96.0,97.0,99.0,99.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),276,Germany,4,155,Western Europe,Country,10.3806066,51.08862743,DEU,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,93.0,93.0,97.0,96.0,96.0,96.0,96.0,96.0,96.0,96.0,95.0,95.0,93.0,93.0,93.0,93.0,93.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),28,Antigua and Barbuda,5,29,Caribbean,Country,-61.7999755,17.07761471,ATG,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,97.0,98.0,99.0,97.0,99.0,99.0,99.0,99.0,99.0,98.0,99.0,98.0,99.0,99.0,99.0,92.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),288,Ghana,5,11,Western Africa,Country,-1.205623522,7.964825185,GHA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,88.0,79.0,78.0,80.0,80.0,84.0,84.0,94.0,93.0,94.0,94.0,91.0,92.0,90.0,98.0,88.0,93.0,99.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),29,Caribbean,4,419,Latin America and the Caribbean,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,71.0,71.0,76.0,70.0,75.0,79.0,79.0,79.0,79.0,79.0,82.0,81.0,82.0,80.0,82.0,80.0,82.0,80.0,83.0,83.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),296,Kiribati,4,57,Micronesia,Country,-157.5643005,1.768837732,KIR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,85.0,77.0,70.0,62.0,79.0,86.0,94.0,82.0,86.0,91.0,99.0,94.0,95.0,75.0,78.0,81.0,90.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),30,Eastern Asia,3,142,Asia,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,86.0,86.0,87.0,87.0,88.0,93.0,93.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),300,Greece,4,39,Southern Europe,Country,22.58307827,39.47301873,GRC,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,89.0,91.0,92.0,94.0,95.0,96.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),308,Grenada,5,29,Caribbean,Country,-61.68248568,12.11238395,GRD,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,96.0,98.0,97.0,83.0,99.0,91.0,96.0,99.0,99.0,97.0,95.0,97.0,97.0,97.0,92.0,96.0,96.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),31,Azerbaijan,4,145,Western Asia,Country,50.01064725,40.39229544,AZE,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,76.0,77.0,76.0,77.0,77.0,75.0,78.0,79.0,81.0,81.0,81.0,87.0,89.0,93.0,94.0,96.0,97.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),32,Argentina,5,5,South America,Country,-65.14563274,-35.19446255,ARG,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,83.0,83.0,93.0,96.0,98.0,98.0,91.0,91.0,93.0,94.0,94.0,91.0,91.0,94.0,94.0,94.0,92.0,86.0,86.0,86.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),320,Guatemala,5,13,Central America,Country,-91.2312746,15.00273719,GTM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,81.0,77.0,82.0,84.0,87.0,87.0,89.0,85.0,95.0,92.0,94.0,88.0,96.0,85.0,73.0,74.0,80.0,82.0,86.0,86.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),324,Guinea,5,11,Western Africa,Country,-11.28173419,11.00210343,GIN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,46.0,50.0,53.0,57.0,60.0,59.0,57.0,63.0,60.0,57.0,64.0,63.0,57.0,50.0,44.0,45.0,45.0,45.0,45.0,45.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),328,Guyana,5,5,South America,Country,-58.97322037,4.788012784,GUY,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,88.0,85.0,91.0,90.0,91.0,93.0,93.0,94.0,93.0,98.0,95.0,93.0,97.0,98.0,98.0,95.0,97.0,97.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),332,Haiti,5,29,Caribbean,Country,-72.33640958,18.40426539,HTI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,43.0,46.0,50.0,53.0,57.0,60.0,62.0,64.0,64.0,65.0,67.0,68.0,66.0,65.0,63.0,64.0,64.0,64.0,64.0,64.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),34,Southern Asia,3,142,Asia,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,61.0,63.0,63.0,65.0,68.0,68.0,68.0,67.0,71.0,74.0,77.0,81.0,81.0,82.0,84.0,86.0,87.0,87.0,87.0,87.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),340,Honduras,5,13,Central America,Country,-86.59974381,14.82243161,HND,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,96.0,95.0,92.0,94.0,98.0,95.0,94.0,93.0,97.0,97.0,97.0,98.0,98.0,98.0,98.0,94.0,89.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),348,Hungary,4,151,Eastern Europe,Country,19.41221519,47.1651448,HUN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),35,South-Eastern Asia,3,142,Asia,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,81.0,81.0,76.0,80.0,82.0,81.0,82.0,82.0,85.0,86.0,85.0,86.0,88.0,83.0,82.0,81.0,86.0,83.0,79.0,79.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),352,Iceland,4,154,Northern Europe,Country,-19.02116966,64.79134763,ISL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,92.0,95.0,97.0,99.0,95.0,97.0,97.0,98.0,96.0,96.0,95.0,89.0,91.0,90.0,92.0,91.0,89.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),356,India,4,34,Southern Asia,Country,79.3608464,22.34642074,IND,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,58.0,59.0,59.0,61.0,63.0,65.0,65.0,64.0,70.0,74.0,79.0,82.0,82.0,83.0,85.0,87.0,88.0,89.0,89.0,89.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),36,Australia,4,53,Australia and New Zealand,Country,134.3499412,-25.57717202,AUS,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,92.0,92.0,93.0,92.0,92.0,92.0,92.0,92.0,92.0,92.0,92.0,92.0,91.0,92.0,93.0,94.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),360,Indonesia,4,35,South-Eastern Asia,Country,113.9174,-0.994582204,IDN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,75.0,76.0,70.0,71.0,71.0,72.0,72.0,73.0,77.0,78.0,81.0,81.0,83.0,85.0,78.0,78.0,79.0,79.0,79.0,79.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),364,Iran (Islamic Republic of),4,34,Southern Asia,Country,54.19766348,32.74370885,IRN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,96.0,99.0,99.0,99.0,95.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,98.0,99.0,98.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),368,Iraq,4,145,Western Asia,Country,43.76606267,33.05013795,IRQ,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,80.0,78.0,77.0,75.0,74.0,65.0,59.0,57.0,69.0,78.0,74.0,81.0,73.0,74.0,72.0,68.0,73.0,85.0,84.0,84.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),372,Ireland,4,154,Northern Europe,Country,-7.121425272,53.25274054,IRL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,86.0,84.0,83.0,86.0,89.0,90.0,91.0,92.0,93.0,94.0,94.0,95.0,95.0,96.0,96.0,95.0,95.0,95.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),376,Israel,4,145,Western Asia,Country,34.62277992,31.06164552,ISR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,92.0,90.0,93.0,95.0,93.0,95.0,95.0,94.0,96.0,95.0,94.0,94.0,96.0,95.0,95.0,94.0,98.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),380,Italy,4,39,Southern Europe,Country,12.57022427,42.79917282,ITA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,87.0,93.0,93.0,96.0,94.0,95.0,96.0,97.0,96.0,96.0,96.0,96.0,97.0,96.0,95.0,93.0,94.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),384,Cte d'Ivoire,5,11,Western Africa,Country,-5.552690016,7.62211586,CIV,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,65.0,66.0,64.0,61.0,67.0,76.0,77.0,76.0,74.0,81.0,85.0,62.0,82.0,75.0,73.0,77.0,85.0,83.0,82.0,82.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),388,Jamaica,5,29,Caribbean,Country,-77.31068409,18.15616857,JAM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,99.0,99.0,96.0,98.0,99.0,95.0,92.0,91.0,90.0,94.0,92.0,96.0,93.0,92.0,91.0,99.0,93.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),39,Southern Europe,3,150,Europe,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,94.0,95.0,96.0,94.0,96.0,96.0,96.0,96.0,96.0,96.0,96.0,97.0,96.0,96.0,95.0,95.0,95.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),392,Japan,4,30,Eastern Asia,Country,139.2716103,36.6554539,JPN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,95.0,96.0,97.0,99.0,98.0,98.0,98.0,98.0,97.0,97.0,97.0,97.0,96.0,96.0,96.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),398,Kazakhstan,4,143,Central Asia,Country,66.65359159,48.01963494,KAZ,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,95.0,95.0,99.0,82.0,98.0,99.0,93.0,99.0,98.0,99.0,99.0,99.0,98.0,95.0,98.0,82.0,99.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),4,Afghanistan,4,34,Southern Asia,Country,66.02688198,33.83160199,AFG,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,24.0,33.0,36.0,41.0,50.0,58.0,58.0,63.0,64.0,63.0,66.0,68.0,67.0,64.0,62.0,65.0,66.0,66.0,66.0,66.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),40,Austria,4,155,Western Europe,Country,14.14172472,47.58704857,AUT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,81.0,84.0,83.0,84.0,83.0,86.0,83.0,85.0,83.0,83.0,86.0,89.0,92.0,95.0,98.0,93.0,87.0,90.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),400,Jordan,4,145,Western Asia,Country,37.13024774,30.65365973,JOR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,99.0,95.0,97.0,95.0,95.0,98.0,98.0,97.0,98.0,98.0,98.0,98.0,98.0,98.0,99.0,98.0,99.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),404,Kenya,5,14,Eastern Africa,Country,37.86096816,0.534797278,KEN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,82.0,80.0,84.0,73.0,73.0,76.0,80.0,81.0,88.0,88.0,90.0,96.0,94.0,87.0,92.0,89.0,89.0,82.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),408,Democratic People's Republic of Korea,4,30,Eastern Asia,Country,127.1803633,40.1462645,PRK,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,56.0,62.0,64.0,68.0,72.0,79.0,89.0,92.0,92.0,93.0,93.0,94.0,96.0,93.0,93.0,96.0,96.0,97.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),410,Republic of Korea,4,30,Eastern Asia,Country,127.8610254,36.45201023,KOR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,97.0,97.0,88.0,96.0,98.0,91.0,94.0,94.0,94.0,99.0,99.0,99.0,99.0,98.0,98.0,97.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),414,Kuwait,4,145,Western Asia,Country,47.49305029,29.53949468,KWT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,99.0,99.0,99.0,98.0,99.0,99.0,99.0,99.0,99.0,98.0,99.0,98.0,99.0,95.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),417,Kyrgyzstan,4,143,Central Asia,Country,74.52324839,41.46204516,KGZ,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,98.0,98.0,99.0,98.0,92.0,94.0,95.0,95.0,96.0,96.0,96.0,97.0,96.0,97.0,96.0,92.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),418,Lao People's Democratic Republic,4,35,South-Eastern Asia,Country,101.9901968,20.27482773,LAO,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,51.0,52.0,53.0,49.0,45.0,49.0,57.0,50.0,61.0,67.0,74.0,78.0,79.0,87.0,88.0,81.0,66.0,69.0,68.0,68.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),419,Latin America and the Caribbean,3,19,Americas,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,90.0,91.0,93.0,93.0,94.0,93.0,93.0,92.0,94.0,93.0,93.0,93.0,90.0,89.0,90.0,89.0,86.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),422,Lebanon,4,145,Western Asia,Country,35.89391711,33.92152458,LBN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,83.0,80.0,77.0,74.0,75.0,77.0,78.0,80.0,81.0,81.0,82.0,82.0,83.0,83.0,83.0,83.0,83.0,83.0,83.0,83.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),426,Lesotho,5,18,Southern Africa,Country,28.25362195,-29.58041814,LSO,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,83.0,78.0,84.0,90.0,90.0,89.0,89.0,88.0,88.0,91.0,93.0,96.0,95.0,93.0,93.0,93.0,93.0,93.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),428,Latvia,4,154,Northern Europe,Country,26.42461876,56.64196636,LVA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,96.0,97.0,97.0,98.0,99.0,99.0,96.0,94.0,94.0,94.0,92.0,92.0,91.0,94.0,92.0,94.0,98.0,98.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),430,Liberia,5,11,Western Africa,Country,-9.311879038,6.448381009,LBR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,46.0,42.0,39.0,35.0,31.0,60.0,60.0,65.0,75.0,81.0,70.0,77.0,80.0,76.0,50.0,52.0,79.0,86.0,84.0,84.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),432,Landlocked developing countries (LLDCs),1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,55.0,57.0,58.0,61.0,63.0,66.0,69.0,70.0,72.0,75.0,77.0,78.0,77.0,76.0,77.0,81.0,80.0,81.0,80.0,80.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),434,Libya,4,15,Northern Africa,Country,18.0295985,27.04042819,LBY,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,94.0,93.0,95.0,97.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,96.0,94.0,97.0,97.0,96.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),44,Bahamas,5,29,Caribbean,Country,-78.05111663,24.69546597,BHS,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,94.0,92.0,93.0,93.0,95.0,95.0,93.0,96.0,99.0,98.0,98.0,97.0,96.0,95.0,94.0,94.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),440,Lithuania,4,154,Northern Europe,Country,23.90517807,55.33680309,LTU,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,95.0,95.0,94.0,94.0,94.0,94.0,95.0,96.0,98.0,95.0,92.0,93.0,93.0,93.0,93.0,94.0,94.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),442,Luxembourg,4,155,Western Europe,Country,6.092656563,49.77679538,LUX,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),450,Madagascar,5,14,Eastern Africa,Country,46.6982339,-19.38514785,MDG,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,57.0,60.0,62.0,66.0,78.0,85.0,85.0,84.0,77.0,77.0,70.0,73.0,70.0,74.0,73.0,69.0,77.0,74.0,75.0,75.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),454,Malawi,5,14,Eastern Africa,Country,33.4884625,-13.40819859,MWI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,75.0,90.0,64.0,84.0,89.0,93.0,99.0,87.0,91.0,93.0,93.0,97.0,96.0,89.0,91.0,88.0,84.0,88.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),458,Malaysia,4,35,South-Eastern Asia,Country,116.8346314,5.452415309,MYS,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,96.0,94.0,96.0,95.0,96.0,95.0,97.0,97.0,97.0,96.0,96.0,97.0,97.0,97.0,99.0,95.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),462,Maldives,4,34,Southern Asia,Country,73.09672546,-0.614385021,MDV,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,98.0,98.0,98.0,96.0,98.0,98.0,98.0,98.0,98.0,96.0,96.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),466,Mali,5,11,Western Africa,Country,-3.522016039,17.35311254,MLI,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,43.0,49.0,61.0,63.0,69.0,77.0,78.0,74.0,74.0,73.0,73.0,66.0,65.0,64.0,66.0,67.0,69.0,70.0,71.0,71.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),470,Malta,4,39,Southern Europe,Country,14.44617519,35.89194275,MLT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,95.0,95.0,94.0,89.0,92.0,85.0,74.0,72.0,73.0,76.0,96.0,99.0,99.0,99.0,97.0,97.0,98.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),478,Mauritania,5,11,Western Africa,Country,-10.33187259,20.26089546,MRT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,51.0,75.0,89.0,76.0,70.0,71.0,68.0,75.0,74.0,64.0,64.0,75.0,80.0,80.0,81.0,73.0,74.0,81.0,81.0,81.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),48,Bahrain,4,145,Western Asia,Country,50.5490754,26.04407747,BHR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,99.0,98.0,97.0,98.0,98.0,98.0,97.0,97.0,98.0,99.0,99.0,99.0,99.0,98.0,98.0,99.0,97.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),480,Mauritius,5,14,Eastern Africa,Country,57.568022,-20.28581998,MUS,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,88.0,92.0,88.0,99.0,98.0,97.0,97.0,97.0,99.0,99.0,99.0,98.0,98.0,98.0,97.0,97.0,96.0,94.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),484,Mexico,5,13,Central America,Country,-102.5148166,23.93378032,MEX,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,97.0,98.0,98.0,98.0,98.0,98.0,96.0,95.0,95.0,97.0,99.0,83.0,87.0,87.0,93.0,85.0,88.0,88.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),485,"Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)",1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,84.0,85.0,81.0,77.0,83.0,84.0,82.0,84.0,86.0,88.0,87.0,87.0,82.0,83.0,82.0,81.0,83.0,85.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),492,Monaco,4,155,Western Europe,Country,7.424214814,43.73532918,MCO,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),496,Mongolia,4,30,Eastern Asia,Country,103.0728057,46.83892054,MNG,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,95.0,98.0,98.0,99.0,99.0,99.0,95.0,96.0,95.0,96.0,99.0,99.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),498,Republic of Moldova,4,151,Eastern Europe,Country,28.4650624,47.20236795,MDA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,97.0,97.0,98.0,98.0,98.0,97.0,92.0,90.0,85.0,90.0,93.0,92.0,90.0,90.0,87.0,89.0,88.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),499,Montenegro,4,39,Southern Europe,Country,19.25214024,42.78717043,MNE,1,1,,,"[2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2006,2018,13,PT,Percentage,G,Global,,,,,,,90.0,92.0,95.0,92.0,94.0,95.0,94.0,94.0,91.0,89.0,89.0,87.0,87.0,87.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),5,South America,4,419,Latin America and the Caribbean,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,90.0,91.0,93.0,94.0,94.0,94.0,93.0,92.0,95.0,94.0,93.0,92.0,93.0,90.0,93.0,89.0,86.0,83.0,83.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),50,Bangladesh,4,34,Southern Asia,Country,89.17660788,22.86961622,BGD,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,82.0,85.0,83.0,87.0,99.0,93.0,94.0,94.0,96.0,97.0,94.0,96.0,94.0,96.0,97.0,98.0,98.0,98.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),504,Morocco,4,15,Northern Africa,Country,-6.281942841,31.8440131,MAR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,96.0,94.0,91.0,97.0,98.0,97.0,95.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),508,Mozambique,5,14,Eastern Africa,Country,38.18479941,-14.27963886,MOZ,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,70.0,73.0,76.0,85.0,83.0,80.0,78.0,75.0,75.0,74.0,74.0,76.0,76.0,78.0,79.0,80.0,80.0,80.0,80.0,80.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),51,Armenia,4,145,Western Asia,Country,44.93839317,40.29499741,ARM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,94.0,94.0,94.0,91.0,90.0,87.0,88.0,89.0,93.0,94.0,95.0,95.0,95.0,93.0,94.0,94.0,94.0,92.0,92.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),512,Oman,4,145,Western Asia,Country,57.87743482,21.98805614,OMN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,99.0,99.0,99.0,98.0,99.0,99.0,98.0,99.0,99.0,98.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),513,Europe and Northern America,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,95.0,95.0,95.0,96.0,96.0,96.0,96.0,96.0,95.0,94.0,94.0,95.0,95.0,93.0,93.0,92.0,93.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),514,Developed Regions,1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,95.0,95.0,95.0,96.0,96.0,96.0,96.0,96.0,95.0,94.0,94.0,95.0,95.0,93.0,93.0,93.0,94.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),515,Developing Regions,1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,70.0,70.0,70.0,72.0,74.0,75.0,76.0,77.0,80.0,82.0,82.0,84.0,83.0,83.0,83.0,84.0,86.0,85.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),516,Namibia,5,18,Southern Africa,Country,17.21907885,-22.13817068,NAM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,79.0,78.0,77.0,79.0,81.0,86.0,86.0,86.0,83.0,83.0,83.0,82.0,84.0,89.0,88.0,92.0,85.0,88.0,89.0,89.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),518,Eastern Asia (excluding Japan),1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,86.0,86.0,86.0,87.0,87.0,93.0,93.0,97.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),52,Barbados,5,29,Caribbean,Country,-59.5346489,13.13648273,BRB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,84.0,87.0,89.0,93.0,92.0,84.0,93.0,85.0,93.0,86.0,91.0,87.0,91.0,94.0,97.0,97.0,90.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),520,Nauru,4,57,Micronesia,Country,166.92313,-0.528742623,NRU,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,44.0,95.0,80.0,80.0,80.0,80.0,72.0,99.0,99.0,99.0,99.0,99.0,79.0,87.0,95.0,91.0,97.0,87.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),524,Nepal,4,34,Southern Asia,Country,83.94678863,28.25866332,NPL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,74.0,72.0,72.0,78.0,80.0,75.0,89.0,82.0,82.0,89.0,82.0,92.0,90.0,92.0,92.0,91.0,87.0,90.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),528,Netherlands,4,155,Western Europe,Country,5.331480568,51.86728884,NLD,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,97.0,98.0,98.0,96.0,96.0,97.0,97.0,97.0,97.0,97.0,97.0,97.0,96.0,95.0,95.0,94.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),53,Australia and New Zealand,3,9,Oceania,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,92.0,92.0,92.0,91.0,91.0,91.0,91.0,91.0,92.0,92.0,93.0,92.0,91.0,92.0,93.0,94.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),54,Melanesia,3,9,Oceania,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,64.0,60.0,65.0,71.0,67.0,75.0,76.0,74.0,68.0,76.0,71.0,76.0,77.0,81.0,76.0,76.0,76.0,67.0,66.0,66.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),543,Oceania (exc. Australia and New Zealand),3,9,Oceania,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,65.0,62.0,66.0,72.0,67.0,75.0,75.0,75.0,68.0,76.0,72.0,76.0,78.0,81.0,76.0,76.0,76.0,68.0,66.0,66.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),548,Vanuatu,4,54,Melanesia,Country,167.0679779,-15.34445547,VUT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,71.0,70.0,70.0,69.0,69.0,68.0,68.0,70.0,73.0,75.0,77.0,79.0,82.0,84.0,86.0,80.0,81.0,85.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),554,New Zealand,4,53,Australia and New Zealand,Country,170.4755673,-43.98721568,NZL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,90.0,90.0,90.0,89.0,89.0,89.0,88.0,89.0,92.0,93.0,95.0,93.0,92.0,93.0,92.0,92.0,94.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),558,Nicaragua,5,13,Central America,Country,-85.03060315,12.84210839,NIC,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,83.0,87.0,85.0,86.0,79.0,86.0,88.0,93.0,97.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),56,Belgium,4,155,Western Europe,Country,4.660976456,50.64104975,BEL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,95.0,95.0,95.0,95.0,97.0,98.0,98.0,99.0,98.0,98.0,98.0,99.0,99.0,99.0,99.0,98.0,98.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),562,Niger,5,11,Western Africa,Country,9.400167877,17.42143036,NER,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,34.0,36.0,39.0,41.0,43.0,45.0,51.0,57.0,67.0,71.0,70.0,75.0,71.0,73.0,81.0,84.0,80.0,85.0,79.0,79.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),566,Nigeria,5,11,Western Africa,Country,8.097363256,9.585789025,NGA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,29.0,27.0,25.0,29.0,33.0,36.0,40.0,42.0,53.0,63.0,54.0,48.0,42.0,43.0,43.0,45.0,57.0,57.0,57.0,57.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),57,Micronesia,3,9,Oceania,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,74.0,73.0,81.0,79.0,70.0,85.0,77.0,89.0,87.0,89.0,89.0,91.0,86.0,87.0,78.0,78.0,76.0,83.0,86.0,86.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),570,Niue,4,61,Polynesia,Country,-169.8601693,-19.05000475,NIU,0,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,95.0,99.0,85.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),578,Norway,4,154,Northern Europe,Country,11.47846389,61.34311134,NOR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,91.0,93.0,92.0,92.0,91.0,94.0,93.0,94.0,94.0,93.0,94.0,95.0,94.0,93.0,95.0,96.0,96.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),583,Micronesia (Federated States of),4,57,Micronesia,Country,158.225216,6.880670092,FSM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,75.0,84.0,92.0,78.0,94.0,67.0,79.0,85.0,91.0,85.0,84.0,81.0,81.0,77.0,72.0,69.0,73.0,75.0,75.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),584,Marshall Islands,4,57,Micronesia,Country,171.0839119,7.110213497,MHL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,39.0,48.0,80.0,68.0,64.0,77.0,74.0,93.0,95.0,96.0,94.0,87.0,80.0,79.0,78.0,85.0,71.0,80.0,81.0,81.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),585,Palau,4,57,Micronesia,Country,134.5733878,7.502307591,PLW,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,96.0,98.0,99.0,99.0,98.0,98.0,98.0,94.0,92.0,49.0,69.0,84.0,89.0,99.0,95.0,90.0,98.0,97.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),586,Pakistan,4,34,Southern Asia,Country,68.80479684,29.36491634,PAK,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,59.0,61.0,63.0,66.0,68.0,63.0,59.0,54.0,53.0,52.0,52.0,63.0,64.0,65.0,69.0,72.0,75.0,75.0,75.0,75.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),591,Panama,5,13,Central America,Country,-81.26616623,8.450965746,PAN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,99.0,99.0,98.0,95.0,92.0,88.0,85.0,86.0,85.0,94.0,87.0,85.0,80.0,80.0,73.0,86.0,81.0,88.0,88.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),598,Papua New Guinea,4,54,Melanesia,Country,145.8587761,-6.756057077,PNG,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,59.0,55.0,61.0,68.0,62.0,72.0,72.0,71.0,63.0,73.0,67.0,72.0,74.0,79.0,73.0,73.0,72.0,62.0,61.0,61.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),600,Paraguay,5,5,South America,Country,-60.54854225,-21.70216237,PRY,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,86.0,89.0,87.0,86.0,92.0,96.0,98.0,95.0,89.0,86.0,91.0,92.0,91.0,91.0,93.0,92.0,92.0,91.0,88.0,88.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),604,Peru,5,5,South America,Country,-71.82093277,-13.58939705,PER,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,90.0,95.0,94.0,86.0,77.0,94.0,93.0,93.0,93.0,93.0,91.0,95.0,88.0,88.0,90.0,89.0,83.0,84.0,84.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),608,Philippines,4,35,South-Eastern Asia,Country,120.8601418,14.16591706,PHL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,78.0,79.0,79.0,84.0,88.0,89.0,88.0,87.0,91.0,87.0,79.0,87.0,88.0,89.0,67.0,60.0,86.0,72.0,65.0,65.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),61,Polynesia,3,9,Oceania,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,90.0,90.0,90.0,75.0,72.0,66.0,75.0,59.0,72.0,81.0,83.0,82.0,85.0,82.0,83.0,81.0,78.0,53.0,53.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),616,Poland,4,151,Eastern Europe,Country,19.40660158,52.1226733,POL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,98.0,98.0,98.0,96.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),62,Central and Southern Asia,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,62.0,64.0,64.0,66.0,69.0,69.0,69.0,68.0,72.0,75.0,78.0,82.0,82.0,82.0,84.0,86.0,87.0,88.0,88.0,88.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),620,Portugal,4,39,Southern Europe,Country,-7.961599811,39.68509315,PRT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,96.0,97.0,98.0,99.0,95.0,93.0,97.0,97.0,97.0,96.0,98.0,97.0,98.0,98.0,98.0,98.0,98.0,98.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),624,Guinea-Bissau,5,11,Western Africa,Country,-14.40182514,12.11760394,GNB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,49.0,53.0,57.0,60.0,64.0,68.0,71.0,74.0,77.0,80.0,83.0,86.0,87.0,87.0,88.0,88.0,88.0,88.0,88.0,88.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),626,Timor-Leste,4,35,South-Eastern Asia,Country,125.9451052,-8.797497247,TLS,1,1,,,"[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2002,2018,17,PT,Percentage,G,Global,,,54.0,55.0,57.0,55.0,63.0,70.0,79.0,72.0,72.0,67.0,83.0,82.0,77.0,76.0,79.0,83.0,83.0,83.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),634,Qatar,4,145,Western Asia,Country,51.19152467,25.28355379,QAT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,80.0,93.0,96.0,92.0,96.0,97.0,96.0,94.0,97.0,99.0,97.0,93.0,92.0,97.0,89.0,99.0,98.0,97.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),64,Bhutan,4,34,Southern Asia,Country,90.45098484,27.39598568,BTN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,92.0,88.0,86.0,95.0,89.0,95.0,95.0,95.0,96.0,93.0,91.0,95.0,97.0,97.0,99.0,99.0,98.0,98.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),642,Romania,4,151,Eastern Europe,Country,24.98481009,45.83893563,ROU,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,98.0,97.0,97.0,97.0,97.0,96.0,96.0,95.0,94.0,89.0,91.0,92.0,94.0,89.0,89.0,82.0,86.0,86.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),643,Russian Federation,4,151,Eastern Europe,Country,99.01404926,61.61899849,RUS,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,96.0,96.0,97.0,96.0,97.0,98.0,98.0,98.0,98.0,98.0,97.0,97.0,97.0,97.0,97.0,97.0,97.0,97.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),646,Rwanda,5,14,Eastern Africa,Country,29.92310194,-1.999842114,RWA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,77.0,88.0,96.0,89.0,95.0,99.0,97.0,97.0,97.0,97.0,97.0,98.0,98.0,98.0,98.0,98.0,98.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),659,Saint Kitts and Nevis,5,29,Caribbean,Country,-62.76628613,17.33994219,KNA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,99.0,96.0,98.0,95.0,99.0,99.0,99.0,98.0,97.0,95.0,97.0,97.0,96.0,97.0,93.0,97.0,97.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),662,Saint Lucia,5,29,Caribbean,Country,-60.96529553,13.89405601,LCA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,70.0,99.0,74.0,90.0,91.0,95.0,85.0,99.0,96.0,95.0,97.0,99.0,98.0,99.0,99.0,99.0,95.0,80.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),670,Saint Vincent and the Grenadines,5,29,Caribbean,Country,-61.19024321,13.24627968,VCT,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,96.0,96.0,97.0,98.0,99.0,99.0,99.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),674,San Marino,4,39,Southern Europe,Country,12.46329038,43.93841766,SMR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,97.0,96.0,96.0,95.0,96.0,92.0,91.0,91.0,90.0,90.0,92.0,89.0,86.0,84.0,85.0,86.0,88.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),678,Sao Tome and Principe,5,17,Middle Africa,Country,6.609772265,0.241554875,STP,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,82.0,92.0,92.0,94.0,96.0,97.0,97.0,97.0,99.0,98.0,98.0,96.0,96.0,97.0,95.0,96.0,96.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),68,Bolivia (Plurinational State of),5,5,South America,Country,-64.66224284,-16.71273412,BOL,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,75.0,71.0,77.0,88.0,84.0,85.0,83.0,84.0,88.0,93.0,91.0,95.0,93.0,87.0,85.0,89.0,87.0,84.0,83.0,83.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),682,Saudi Arabia,4,145,Western Asia,Country,44.54763347,24.12594211,SAU,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,97.0,95.0,95.0,96.0,96.0,96.0,96.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),686,Senegal,5,11,Western Africa,Country,-14.46636926,14.35920905,SEN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,52.0,52.0,60.0,73.0,87.0,84.0,89.0,94.0,88.0,86.0,89.0,92.0,91.0,92.0,89.0,89.0,93.0,93.0,81.0,81.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),688,Serbia,4,39,Southern Europe,Country,20.805876,44.03145697,SRB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,93.0,95.0,89.0,88.0,98.0,92.0,94.0,95.0,95.0,91.0,94.0,91.0,95.0,93.0,95.0,92.0,95.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),690,Seychelles,5,14,Eastern Africa,Country,55.46561591,-4.678053059,SYC,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,96.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,98.0,98.0,99.0,97.0,96.0,97.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),694,Sierra Leone,5,11,Western Africa,Country,-11.78306584,8.568604164,SLE,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,44.0,38.0,53.0,73.0,65.0,65.0,64.0,64.0,77.0,84.0,86.0,89.0,91.0,92.0,83.0,86.0,84.0,90.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),70,Bosnia and Herzegovina,4,39,Southern Europe,Country,17.78584332,44.16845548,BIH,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,91.0,80.0,87.0,84.0,93.0,87.0,95.0,91.0,90.0,89.0,88.0,92.0,89.0,86.0,82.0,78.0,75.0,73.0,73.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),702,Singapore,4,35,South-Eastern Asia,Country,103.8107883,1.361009155,SGP,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,96.0,94.0,96.0,95.0,96.0,95.0,97.0,97.0,97.0,96.0,96.0,97.0,97.0,96.0,96.0,97.0,96.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),703,Slovakia,4,151,Eastern Europe,Country,19.48495604,48.70741446,SVK,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,98.0,97.0,96.0,96.0,96.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),704,Viet Nam,4,35,South-Eastern Asia,Country,105.802499,10.09643079,VNM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,96.0,96.0,75.0,99.0,96.0,95.0,94.0,92.0,93.0,96.0,93.0,95.0,97.0,59.0,95.0,97.0,96.0,94.0,75.0,75.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),705,Slovenia,4,39,Southern Europe,Country,14.82209486,46.11958061,SVN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,92.0,93.0,95.0,94.0,95.0,97.0,97.0,97.0,96.0,96.0,96.0,96.0,95.0,95.0,95.0,94.0,94.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),706,Somalia,5,14,Eastern Africa,Country,46.20367477,4.406485729,SOM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,33.0,33.0,40.0,40.0,30.0,35.0,26.0,40.0,31.0,42.0,45.0,41.0,42.0,42.0,42.0,42.0,42.0,42.0,42.0,42.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),710,South Africa,5,18,Southern Africa,Country,24.67184355,-29.99957544,ZAF,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,73.0,71.0,70.0,69.0,74.0,81.0,84.0,85.0,82.0,81.0,77.0,75.0,71.0,81.0,85.0,85.0,76.0,76.0,74.0,74.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),716,Zimbabwe,5,14,Eastern Africa,Country,29.86909584,-19.00075492,ZWE,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,78.0,75.0,71.0,68.0,65.0,68.0,70.0,73.0,75.0,73.0,89.0,93.0,95.0,95.0,91.0,87.0,90.0,89.0,89.0,89.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),72,Botswana,5,18,Southern Africa,Country,23.81380223,-22.18810073,BWA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,97.0,96.0,96.0,96.0,96.0,96.0,96.0,96.0,95.0,95.0,95.0,95.0,95.0,95.0,95.0,95.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),722,Small island developing States (SIDS),1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,71.0,71.0,74.0,72.0,74.0,78.0,79.0,79.0,78.0,80.0,81.0,81.0,83.0,83.0,82.0,82.0,82.0,79.0,81.0,81.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),724,Spain,4,39,Southern Europe,Country,-3.554078296,40.39211472,ESP,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,96.0,98.0,98.0,97.0,96.0,98.0,96.0,97.0,96.0,97.0,97.0,97.0,96.0,97.0,97.0,97.0,95.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),728,South Sudan,5,14,Eastern Africa,Country,30.32618773,7.290839152,SSD,1,1,,,"[2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2011,2018,8,PT,Percentage,G,Global,,,,,,,,,,,,61.0,63.0,53.0,50.0,46.0,45.0,47.0,49.0,49.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),729,Sudan,4,15,Northern Africa,Country,29.95650159,16.02643066,SDN,0,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,62.0,66.0,60.0,69.0,74.0,78.0,78.0,84.0,86.0,81.0,90.0,93.0,92.0,93.0,94.0,93.0,93.0,95.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),738,Sub-Saharan Africa (inc. Sudan),1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,51.0,51.0,53.0,55.0,59.0,62.0,63.0,67.0,69.0,72.0,71.0,71.0,70.0,70.0,72.0,73.0,75.0,76.0,76.0,76.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),740,Suriname,5,5,South America,Country,-55.90626394,4.132603197,SUR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,71.0,68.0,73.0,75.0,85.0,83.0,84.0,84.0,85.0,87.0,96.0,86.0,84.0,86.0,85.0,89.0,91.0,81.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),746,Northern Africa (exc. Sudan),1,,,Group,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,96.0,94.0,94.0,95.0,96.0,97.0,97.0,97.0,97.0,97.0,96.0,95.0,97.0,95.0,95.0,95.0,94.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),747,Northern Africa and Western Asia,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,86.0,83.0,82.0,86.0,87.0,87.0,89.0,90.0,90.0,91.0,91.0,88.0,90.0,89.0,89.0,89.0,90.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),748,Eswatini,5,18,Southern Africa,Country,31.50149288,-26.56471011,SWZ,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,84.0,84.0,85.0,85.0,86.0,86.0,87.0,87.0,88.0,88.0,89.0,91.0,95.0,98.0,98.0,90.0,90.0,90.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),752,Sweden,4,154,Northern Europe,Country,14.3775338,60.60103109,SWE,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,99.0,99.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,98.0,97.0,98.0,98.0,97.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),753,Eastern and South-Eastern Asia,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,83.0,84.0,82.0,84.0,85.0,85.0,89.0,89.0,92.0,94.0,94.0,94.0,95.0,93.0,92.0,92.0,94.0,93.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),756,Switzerland,4,155,Western Europe,Country,8.223158,46.96617097,CHE,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,93.0,93.0,93.0,93.0,93.0,94.0,94.0,94.0,95.0,95.0,95.0,96.0,96.0,96.0,96.0,96.0,96.0,97.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),76,Brazil,5,5,South America,Country,-53.08432878,-10.77668561,BRA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,95.0,97.0,93.0,96.0,89.0,89.0,83.0,83.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),760,Syrian Arab Republic,4,145,Western Asia,Country,38.50466565,35.01676176,SYR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,84.0,82.0,84.0,83.0,81.0,80.0,80.0,80.0,79.0,80.0,80.0,72.0,45.0,41.0,43.0,41.0,42.0,48.0,47.0,47.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),762,Tajikistan,4,143,Central Asia,Country,69.294998,38.43069666,TJK,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,83.0,85.0,85.0,85.0,86.0,84.0,83.0,86.0,86.0,93.0,93.0,96.0,94.0,96.0,97.0,96.0,96.0,96.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),764,Thailand,4,35,South-Eastern Asia,Country,101.0202951,15.13089239,THA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,96.0,96.0,98.0,98.0,98.0,98.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),768,Togo,5,11,Western Africa,Country,0.97835765,8.532096072,TGO,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,64.0,50.0,59.0,72.0,71.0,82.0,84.0,82.0,81.0,78.0,83.0,85.0,84.0,84.0,87.0,88.0,89.0,90.0,88.0,88.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),776,Tonga,4,61,Polynesia,Country,-175.1959991,-21.19511329,TON,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,89.0,84.0,90.0,90.0,89.0,88.0,87.0,86.0,84.0,82.0,82.0,77.0,82.0,80.0,78.0,78.0,81.0,81.0,81.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),780,Trinidad and Tobago,5,29,Caribbean,Country,-61.29389504,10.41877263,TTO,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,91.0,96.0,91.0,94.0,95.0,92.0,88.0,90.0,90.0,90.0,90.0,92.0,92.0,92.0,96.0,97.0,89.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),784,United Arab Emirates,4,145,Western Asia,Country,53.98279159,23.43322219,ARE,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,94.0,94.0,94.0,94.0,94.0,92.0,92.0,92.0,93.0,94.0,95.0,96.0,98.0,99.0,99.0,99.0,97.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),788,Tunisia,4,15,Northern Africa,Country,9.572737411,34.11439971,TUN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,98.0,96.0,95.0,97.0,98.0,99.0,98.0,99.0,99.0,98.0,98.0,97.0,98.0,98.0,98.0,98.0,98.0,97.0,97.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),792,Turkey,4,145,Western Asia,Country,35.42890329,38.9899684,TUR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,88.0,78.0,68.0,85.0,90.0,90.0,96.0,96.0,96.0,97.0,97.0,97.0,98.0,96.0,97.0,98.0,96.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),795,Turkmenistan,4,143,Central Asia,Country,58.9787665,40.0912346,TKM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,95.0,98.0,83.0,97.0,99.0,98.0,98.0,96.0,96.0,96.0,97.0,97.0,98.0,98.0,99.0,98.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),798,Tuvalu,4,61,Polynesia,Country,178.6679611,-7.460048071,TUV,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,82.0,96.0,98.0,93.0,98.0,93.0,97.0,97.0,99.0,88.0,89.0,96.0,97.0,90.0,89.0,96.0,94.0,96.0,89.0,89.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),8,Albania,4,39,Southern Europe,Country,20.06660928,41.13897007,ALB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,97.0,97.0,98.0,97.0,97.0,98.0,97.0,98.0,99.0,98.0,99.0,99.0,99.0,99.0,98.0,99.0,98.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),800,Uganda,5,14,Eastern Africa,Country,32.39100438,1.279557331,UGA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,52.0,55.0,57.0,59.0,62.0,64.0,64.0,73.0,71.0,79.0,80.0,82.0,83.0,84.0,85.0,89.0,93.0,94.0,93.0,93.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),804,Ukraine,4,151,Eastern Europe,Country,31.40270802,49.00735945,UKR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,97.0,99.0,96.0,98.0,98.0,90.0,71.0,52.0,50.0,76.0,76.0,23.0,23.0,19.0,50.0,50.0,50.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),807,North Macedonia,4,39,Southern Europe,Country,21.7007909,41.60048068,MKD,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,95.0,91.0,96.0,96.0,94.0,97.0,93.0,95.0,95.0,96.0,95.0,96.0,95.0,98.0,95.0,91.0,95.0,91.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),818,Egypt,4,15,Northern Africa,Country,29.77468534,26.57438204,EGY,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,99.0,97.0,98.0,97.0,98.0,98.0,98.0,97.0,97.0,97.0,96.0,93.0,97.0,94.0,93.0,95.0,94.0,95.0,95.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),826,United Kingdom of Great Britain and Northern Ireland,4,154,Northern Europe,Country,-2.23830539,53.27691757,GBR,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,91.0,91.0,91.0,92.0,91.0,92.0,92.0,92.0,93.0,94.0,95.0,95.0,95.0,95.0,95.0,94.0,94.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),834,United Republic of Tanzania,5,14,Eastern Africa,Country,34.80521182,-6.265332606,TZA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,79.0,87.0,89.0,95.0,95.0,90.0,90.0,83.0,86.0,85.0,91.0,90.0,92.0,91.0,97.0,98.0,97.0,97.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),84,Belize,5,13,Central America,Country,-88.70199554,17.19965901,BLZ,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,91.0,96.0,89.0,96.0,97.0,96.0,98.0,96.0,94.0,97.0,96.0,95.0,98.0,95.0,95.0,94.0,95.0,88.0,96.0,96.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),840,United States of America,4,21,Northern America,Country,-99.13830311,39.5277871,USA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,94.0,94.0,94.0,96.0,96.0,96.0,96.0,96.0,96.0,95.0,95.0,96.0,94.0,94.0,95.0,95.0,95.0,95.0,94.0,94.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),854,Burkina Faso,5,11,Western Africa,Country,-1.742843829,12.27491081,BFA,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,45.0,62.0,69.0,79.0,79.0,82.0,86.0,89.0,93.0,92.0,91.0,91.0,90.0,88.0,91.0,91.0,91.0,91.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),858,Uruguay,5,5,South America,Country,-56.01387025,-32.8002838,URY,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,90.0,94.0,95.0,91.0,94.0,96.0,95.0,94.0,94.0,95.0,95.0,95.0,95.0,94.0,95.0,95.0,95.0,93.0,91.0,91.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),860,Uzbekistan,4,143,Central Asia,Country,63.11944558,41.77560518,UZB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,99.0,99.0,98.0,99.0,99.0,96.0,96.0,98.0,98.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,98.0,98.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),862,Venezuela (Bolivarian Republic of),5,5,South America,Country,-66.15642084,7.121324748,VEN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,77.0,70.0,65.0,68.0,86.0,87.0,71.0,62.0,50.0,84.0,78.0,78.0,81.0,82.0,78.0,87.0,84.0,66.0,60.0,60.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),882,Samoa,4,61,Polynesia,Country,-172.4430749,-13.61541469,WSM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,98.0,90.0,92.0,90.0,63.0,59.0,50.0,65.0,39.0,64.0,78.0,82.0,82.0,85.0,81.0,84.0,80.0,74.0,34.0,34.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),887,Yemen,4,145,Western Asia,Country,45.22389143,15.22242099,YEM,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,74.0,73.0,65.0,61.0,72.0,79.0,78.0,79.0,78.0,76.0,76.0,69.0,67.0,73.0,73.0,69.0,71.0,68.0,65.0,65.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),894,Zambia,5,14,Eastern Africa,Country,27.850329,-14.59701056,ZMB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,85.0,85.0,84.0,83.0,83.0,82.0,81.0,80.0,87.0,94.0,83.0,81.0,78.0,79.0,86.0,90.0,91.0,94.0,90.0,90.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),9,Oceania,2,1,World,Region,,,,,,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,79.0,78.0,80.0,83.0,81.0,84.0,85.0,84.0,81.0,85.0,83.0,86.0,86.0,87.0,85.0,86.0,86.0,83.0,82.0,82.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),90,Solomon Islands,4,54,Melanesia,Country,160.1584117,-9.622391719,SLB,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,86.0,84.0,78.0,84.0,90.0,89.0,99.0,88.0,85.0,86.0,83.0,91.0,92.0,83.0,77.0,87.0,94.0,83.0,85.0,85.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.02,"['health', 'vaccination']",SH_ACS_DTP3,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),96,Brunei Darussalam,4,35,South-Eastern Asia,Country,114.6288563,4.49736984,BRN,1,1,,,"[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2000,2018,19,PT,Percentage,G,Global,99.0,97.0,94.0,92.0,92.0,94.0,97.0,99.0,98.0,99.0,95.0,97.0,95.0,99.0,99.0,99.0,99.0,99.0,99.0,99.0,,,,"WHO/UNICEF coverage estimates 2018 revision, July 2019",,E: Estimated data
